Pfizer Inc
PFEToday
-0.36%
5 Days
+0.08%
1 Month
-3.26%
6 Months
+2.72%
Year to Date
-6.14%
1 Year
-5.75%
TradingKey Stock Score of Pfizer Inc
Currency: USD Updated: 2025-12-30Key Insights
Pfizer Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 62/158 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 29.11.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Pfizer Inc's Score
Support & Resistance
Score Analysis
Analyst Rating
Pfizer Inc Highlights
Pfizer Inc News
China Adds Eli Lilly and Pfizer to Its First Private Insurance List — Is This a Buying Opportunity for Biotech Investors?
TradingKey - China officially unveiled its first list of innovative drugs covered by commercial health insurance on December 7, greenlighting 19 high-priced therapies previously excluded from the National Reimbursement Drug List (NRDL).
Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
NEW YORK/LONDON, Nov 8 (Reuters) - U.S. drugmaker Pfizer has PFE.N clinched a $10 billion deal for obesity drug developer Metsera MTSR.O, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk NOVOb.CO.
[Reuters Breakingviews] Obesity kings’ buffet is slimmer than it looks
Obesity kings’ plump future is under siege. Over the past month Roche ROG.S and Pfizer PFE.N have splurged over $10 billion scooping up promising treatments and other rivals are rapidly developing their own medicines. Incumbents $242 billion Novo Nordisk NOVOb.CO and $722 billion Eli Lilly LLY.N may
Why BioNTech Stock Jumped by Nearly 4% on Wednesday
Key PointsThe biotech continues to embrace artificial intelligence (AI) technology, which is heartening for investors.It owns and manages an AI developer, InstaDeep.10 stocks we like better than BioNTech Se › Germany-based BioNTech (NASDAQ: BNTX) saw its U.S. listed stock enjoy a mini-pop on Wednesd
Trump Strikes First Drug Deal: Pfizer Cuts Prices in Exchange for Tariff Relief
TradingKey - On Tuesday, U.S. President Donald Trump announced an agreement with Pfizer under which the pharmaceutical giant will voluntarily slash prices for its drugs in the U.S. market.
Trump executive order demands pharma industry price cuts
WASHINGTON, May 12 (Reuters) - U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with what other countries pay that analysts and legal experts said would be difficult to implement.
Financial Indicators
EPS
Total revenue
Pfizer Inc Info
FAQs
What is the current price of Pfizer Inc (PFE)?
What is the symbol of Pfizer Inc?
What is the 52-week high of Pfizer Inc?
What is the 52-week low of Pfizer Inc?
What is the market capitalization of Pfizer Inc?
What is the net income of Pfizer Inc?
Is Pfizer Inc (PFE) currently rated as Buy, Hold, or Sell?
What is the Earnings Per Share (EPS TTM) of Pfizer Inc (PFE)?
Related Instruments
